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ABSTRACT
TFIIH is a multisubunit factor essential for tran-
scription initiation and promoter escape of RNA
polymerase II and for the opening of damaged
DNA double strands in nucleotide excision repair
(NER). In this study, we have analyzed at which
step of the transcription cycle TFIIH is essential for
transcription by RNA polymerase I. We demonstrate
that TFIIH associates with the rDNA promoter and
gene-internal sequences and leaves the rDNA
promoter in a complex with RNA polymerase I
after start of transcription. Moreover, mutations in
the TFIIH subunits XPB and XPD found in Cockayne
syndrome impair the interaction of TFIIH with the
rDNA, but do not influence initiation complex forma-
tion or promoter escape of RNA polymerase I, but
preclude the productivity of the enzyme by reducing
transcription elongation in vivo and in vitro. Our
results implicate that reduced RNA polymerase I
transcription elongation and ribosomal stress
could be one factor contributing to the Cockayne
syndrome phenotype.
INTRODUCTION
RNA polymerases are dependent on auxiliary factors
to recognize their promoters and to initiate, elongate
and terminate transcription. These transcription factors
are speciﬁc for each class of RNA polymerase.
TATA-binding protein (TBP) was the ﬁrst transcription
factor shown to be essential for all three classes of RNA
polymerases (1,2). TFIIH, which was supposed to be pri-
marily a general transcription factor of RNA polymerase
II, was described to play an essential role in RNA poly-
merase I transcription (3–5). TFIIH can be isolated in a
complex with RNA polymerase I, the basal initiation
factor TIF-IB and with the DNA repair factors CSB
and XPG. TFIIH is essential for rDNA transcription
in vivo and in vitro and resides in the nucleolus where
photobleaching experiments determined a residence time
of 25s in comparison to 6s at a RNA polymerase II
promoter indicating a differing function of TFIIH in Pol
I than in Pol II transcription.
TFIIH is a basal or general transcription factor of RNA
polymerase II and necessary for the transcription of every
protein-coding gene. TFIIH is composed of 10 subunits
with three enzymatic activities, the ATP-dependent
helicases XPB and XPD and the CAK sub-complex with
the kinase cdk7. The ATPase domain of the helicase XPB
opens the DNA double strand at the promoter (6) and
creates the transcription bubble. XPB plays a major role
in promoter escape, a phase of instability and pausing of
the early elongation phase until nucleotide 15, whereas
XPD is a necessary structural component for this step
(7,8). The cdk7 subunit of TFIIH phosphorylates the
C-terminal domain (CTD) of the largest subunit of
RNA polymerase II and thus initiates elongation. Thus
TFIIH is involved in initiation, promoter clearance and
elongation of RNA polymerase II.
Mutations in TFIIH subunits cause three distinct
diseases: the cancer prone skin disease xeroderma pig-
mentosum (XP) and the premature aging diseases
trichothiodystrophy (TTD) and Cockayne syndrome
(CS) (9). XP is due to non-repaired DNA lesions. In nu-
cleotide excision repair (NER), the XPB and XPD
subunits of TFIIH serve an essential function in opening
the DNA strand around helix distorting lesions and the
accumulation of UV-induced DNA damage is highly
mutagenic.
The pathomechanisms of the premature aging pheno-
types of CS and TTD are less well deﬁned. As a
sub-pathway of NER is defective in these tumor-free syn-
dromes, accumulating DNA damage could drive tumor
suppression at the expense of premature aging (10).
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NER factor XPA is not followed by premature aging, thus
indicating that the mutations causing premature aging
might impair another common function of the involved
genes. As TFIIH is a basal transcription factor, transcrip-
tional deﬁciencies might be causal for premature aging
(11–13).
In this study, we have investigated at which step of the
transcription cycle TFIIH is involved in RNA polymerase
I transcription. TFIIH binds to the rDNA promoter and
gene-internal sequences and leaves the rDNA promoter
with the polymerase and complexes with the polymerase
during transcription. Mutations in the helicase subunits of
TFIIH found in CS impair the interaction of the factor
with the rDNA in vivo and in vitro and severely reduce
Pol I transcription. Puriﬁed TFIIH stimulates the elong-
ation activity of RNA polymerase I. TFIIH is not needed
for efﬁcient initiation complex formation and does not
inﬂuence the stability of RNA polymerase I–template
interaction after transcription start, but is essential for
productive transcription. Our study revealed a novel role
for TFIIH as an elongation factor of RNA polymerase I.
Elongation of RNA polymerase I transcription might be a
common function of CS-causing genes.
MATERIAL AND METHODS
Cell growth
HEK 293 and HeLa cells were grown in Dulbecco’s
MEM (PAA Laboratories GmbH) medium with addition-
al 10% fetal calf serum (Biochrom AG) as well as L-glu-
tamine (Biochrom AG), penicillin G and streptomycin
(Pen-Strep, Biochrom AG).
XPA/XP cells from a XP patient complementation
group A (GM02344), XPB/CS cells from patient
XP11BE (GM02252,14) and XPD/CS cells from patient
XP-CS2 (GM03249,15) were obtained from the Coriell
Institute for Medical Research and grown in RPMI 1640
(PAA Laboratories GmbH) supplemented with15% fetal
calf serum (Lonza Group Ltd.), L-glutamine (Biochrom
AG) and penicillin G and streptomycin (Pen-Strep,
Biochrom AG). The XPB/CS mutations from patient
XP11BE (GM02252) result in a paternal allele with a
stop codon in exon 6 (14) that is not detectable at the
RNA level (16) and a maternal allele that contains a
transversion at a splice acceptor site and an inactivating
frameshift at the last 41 amino acids of the C-terminus
(15). Accordingly the XPD/CS cells from patient
XP-CS2 (GM03249) express XPD from a single allele
mutated in the DNA-binding domain of helicase motiv
V (G602D) (17). Transcriptionally active nuclear extracts
were prepared from logarithmically growing mammalian
cell culture as described (18).
Cell transfection
Using amaxa nucleofector I (Lonza) device, a transfection
protocol was established with a plasmid encoding GFP.
An amount of 4mg pcDNA, pcDNA XPB and XPD were
transfected in 4 10
6 cells by electroporation and RNA
was harvested from 1 10
6 cells with RNeasy Plus Kit
(Qiagen). For western blots cells were lysed by a buffer
containing 1% Triton X-100.
RNA analysis
Exponentially growing cells of equal density were har-
vested by centrifugation. Total cellular RNA was
prepared from XPA/XP-, XPB/CS- and XPD/CS- cells
by using the peqGold TriFast reagent (Peqlab
Biotechnologie GmbH). RNA (1mg) was reverse
transcribed using random primer p(dN)6 (F.Hoffmann-
La Roche Ltd.) and 45S pre rRNA was quantiﬁed by
real time PCR (LightCycler, F.Hoffmann-La Roche
Ltd.) using primers that amplify a fragment from +307
to +442 of the human rDNA (hrDNA primer, Thermo
Fischer Scientiﬁc GmbH: forward 50-TGT CAG GCG
TTC TCG TCT C-30; reverse 50-AGC ACG ACG TCA
CCA TAT C-30). Data were normalized to the level of
GAPDH mRNA (GAPDH primer, Thermo Fischer
Scientiﬁc GmbH: forward 50-TGG ACC TGA CCT
GCC GTC TA-30; reverse 50-CCC TGT TGC TGT
AGC CAA ATT C-30). Northern blot analysis of the
45S rRNA was performed as described (19).
Puriﬁcation of TFIIH
A HeLa cell line stably expressing FLAG-tagged XPB (20)
was used for the puriﬁcation of TFIIH. An amount of
2.5mg nuclear extract was incubated with anti-FLAG
M2-agarose beads (Sigma-Aldrich Co.) in the presence
of protease inhibitors on the rotating wheel at 4 C over
night. After two washes with AM300+0.1% NP-40,
bound TFIIH was eluted from the beads by incubation
at 4 C for 2h in AM300+0.1% NP-40 plus 0.25mg/ml
FLAG peptide and subsequently dialyzed against buffer
AM100.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were done
as described with minor modiﬁcations (21,22). After pre-
cipitation and washing, crosslinked proteins were digested
by incubation with elution buffer (TE buffer; 1% SDS)
and Proteinase K for 2h at 68 C. DNA was extracted
using the QIAquick Nucleotide Removal Kit (QIAGEN
GmbH) and analyzed by PCR. The primers used for PCR
have been published with the names: H0 (rDNA
promoter); H1, H4, H8 and H13 (gene-internal) and
H23/27 [intergenic spacer (IGS)] (23). Statistical analysis
of qPCR was performed according to Tukey’s multiple
comparison test.
Template immunoprecipitation
An amount of 40ng rDNA template (pHrP2 linearized
with EcoRI) was incubated with 40mg of the indicated
nuclear extracts and 0.825mmol guanine for 40min at
30 C and 350rpm. Addition of sarcosyl (ﬁnal concen-
tration: 0.025%) and salmon sperm DNA (ﬁnal concen-
tration: 400ng) was used to provide single-round
transcription. Transcription was started by adding
ribonucleotides and stopped after the indicated time by
crosslinking proteins to the template with formaldehyde
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was stopped with glycine (ﬁnal concentration 0.125 M) for
5min at 30 C. Each sample was diluted with IP buffer and
incubated with indicated antibodies over night at 4 C.
Isolation of precipitated complexes, washing steps, diges-
tion of proteins and DNA extraction as well as DNA
ampliﬁcation was done as described for ChIP analysis.
Preparation of immobilized template and isolation of
pre-initiation complexes
The preparation of immobilized complexes has been
described previously (22).
In vitro transcription
In vitro transcription assays were done as described (22).
Protein detection
Proteins were analyzed by immunoblotting. Proteins from
eluates of immobilized complexes or nuclear extracts
were separated by SDS–PAGE and transferred to nitro-
cellulose membrane (Whatman GmbH). Adequate sec-
ondary antibodies conjugated to horseradish peroxidase
were used to detect immunocomplexes on the membrane
by chemoluminescence according to the instructions of
the manufacture (LumiGLO Reagent, Cell Signaling
Technology).
Antibodies
a-actin, a-XPB, a-XPD, a-cdk7 and a-p62 were obtained
from Santa Cruz (Santa Cruz Biotechnology, Inc.). a-Pol
II CTD, a-XPB and a-XPD antibodies recognizing
mutant subunits were purchased from Acris (Acris
Antibodies GmbH). a-RPA116, a-TAF1110, a-TAF168,
a-UBF and a-TIF IA were kindly provided by Ingrid
Grummt. a-RPA135 was harvested from rabbits
immunized with a mixture of two synthetic peptides
(MDPGSRWRNLPSGPSC,LEKPPPSWSAMRNRKYNC;
Peptide Specialty Laboratories GmbH). The a-p44 was
afﬁnity puriﬁed from rabbit serum immunized with one
synthetic peptide (MDEEPERTKRWEGGYER; Peptide
Specialty Laboratories GmbH).
RESULTS
The rDNA is decorated with TFIIH
Recently, it has been suggested that TFIIH plays an es-
sential role in RNA polymerase I transcription. TFIIH
can be identiﬁed in functional complexes with RNA
polymerase I in the nucleolus and initiation factors and
is essential for RNA polymerase I transcription in vitro
and in vivo (3–5).
To elucidate the mechanisms of TFIIH action on rDNA
transcription, we ﬁrst asked if TFIIH is part of the initi-
ation complex and binds to the rDNA promoter in vitro.
Bead-bound immobilized rDNA template was used to
isolate initiation complexes by incubation with HeLa
nuclear extracts, followed by washing with buffer
AM100 and elution of bound proteins with urea.
Western blot analysis (Figure 1A) of these immobilized
complexes (IC) revealed speciﬁc binding of RNA polymer-
ase I and initiation factors SL1, UBF and TIF-IA to the
rDNA promoter. TFIIH subunits could clearly be
detected in these immobilized complexes thus indicating
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Figure 1. TFIIH binds to the rDNA in vitro and in vivo. (A) One micro-
gram of biotin labeled rDNA was bound to 20ml of streptavidin magnetic
beads and incubated with HeLa nuclear extract. After washing with
buffer AM containing 100mM KCl, bound proteins were eluted with
4 M urea and analyzed on western blots with the indicated antibodies.
(Pol II-RNA polymerase II, Pol I-RNA polymerase I, TAFI110/
TAFI68-subunits of selectivity factor 1, UBF-upstream binding factor,
TIF-IA-transcription initiation factor IA, XPB/XPD/cdk7/p44-subunits
of transcription factor of RNA polymerase II H). To control the speci-
ﬁcity of binding, immobilized complexes formed on speciﬁc (pHrP2) and
unspeciﬁc (pUC) DNA were washed with buffer AM100 containing
0.125% sarcosyl. Binding of RNA polymerase I and TFIIH was
stronger to the human rDNA promoter than to unspeciﬁc DNA. (B)
ChIPanalysis with chromatin from HeLa cells expressing ﬂag-tagged
XPB (20). The antibodies are indicated above (a-TFIIH=a-ﬂag). For
PCR analysis, primers amplifying the IGS or promoter and gene-internal
regions (H1, H4, H8) were used as depicted. Primer position is described
in detail in O’Sullivan et al. (23). Promoter region and IGS from three
independent experiments was analyzed by qPCR and normalized to the
respective negative controls (***P<0.001; *P<0.05). Pictures are rep-
resentatives from at least three independent experiments.
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to the rDNA in vitro. RNA polymerase I and TFIIH
did also bind to immobilized pUC DNA. However,
these complexes were not resistant to washing with
buffer AM 100 in the presence of sarcosyl. To ascertain
whether TFIIH directly binds to the rDNA promoter
region in vivo, we performed ChIP analysis with HeLa
cells expressing a ﬂag-tagged XPB subunit of TFIIH
(20). Antibodies against RNA polymerase I and CSB
precipitated promoter and gene-internal regions of the
rDNA (Figure 1B) (22). Flag-antibodies recognizing the
tagged TFIIH subunit XPB speciﬁcally precipitated
the rDNA promoter and all gene-internal sequences of
the rDNA, but not the IGS. Real-time PCR analysis
revealed signiﬁcant binding of RNA polymerase I
and TFIIH to the promoter, but not to the IGS. Hence,
TFIIH directly binds to the rDNA promoter. Moreover,
TFIIH is also bound to the coding rDNA sequences,
implying a post-initiation role for TFIIH in RNA poly-
merase I transcription.
TFIIH leaves the rDNA promoter in a complex with
RNA polymerase I
The 0.025% sarcosyl reduces transcription to a single
round by precluding initiation complex formation,
but allowing transcription from preformed initiation
complexes (Figure 2A, compare lane 4 to lane 8). We
asked whether TFIIH leaves the initiation complex after
transcription initiation. Immobilized complexes were
challenged by the addition of nucleotides (NTPs) and
transcription restricted to a single round by sarcosyl.
Proteins remaining on the template after single-round
transcription and the supernatants were analyzed in
western blots. Under these conditions RNA polymerase
I left completely the template whereas UBF stayed
bound to the rDNA (Figure 2B). Similar to RNA poly-
merase I, TFIIH is completely released from the rDNA
template by the addition of nucleotides and can be
detected in the supernatant.
As TFIIH binding to the rDNA can be determined
throughout the whole gene we next asked if TFIIH
travels with the polymerase and can be detected in
a complex after transcription or is released and able
to re-initiate transcription. This was addressed by
co-immunoprecipitation experiments with supernatants
after one round of transcription (Figure 2C). Antibodies
directed against RNA polymerase I clearly co-precipitated
TFIIH after transcription. Thus, TFIIH associates with
RNA polymerase I during transcription and does not
leave the elongating enzyme.
Template-immunoprecipitation reveals binding of TFIIH
to the rDNA throughout the whole transcription process
As the human rDNA promoter extends over the tran-
scription start side, a construction of a g-less cassette to
directly study elongation is not possible. To investigate the
protein–DNA interactions after transcription start, we de-
veloped an assay combining in vitro transcription with
formaldehyde crosslinking and immunoprecipitation
followed by semi-quantitative PCR analysis. In this
assay after synchronization of the reaction through for-
mation of initiated complexes by pre-incubation of
template with nuclear extracts in the presence of the ﬁrst
nucleotides, we determined single-round transcription
kinetics by starting transcription reaction by addition of
the missing nucleotides (Figure 3A). After linear increase
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Figure 2. TFIIH leaves the rDNA promoter with RNA polymerase I.
(A) In vitro transcription experiment with HeLa nuclear extract titrating
the sarcosyl concentration for single-round transcription. (B)
Bead-bound immobilized complexes (IC HeLa) were challenged by
the addition of nucleotides (NTPs). Transcription was restricted to a
single round by sarcosyl and the remaining proteins analyzed after urea
elution by western blots. Sarcosyl/NTPs denominates the single-round
transcription experiment and sarcosyl the control reaction without nu-
cleotides. RNA polymerase I and the XPB subunit of TFIIH were also
monitored in the supernatants. (C) Supernatants of single-round tran-
scriptions with immobilized-complex isolated transcription factors were
subject to immunoprecipitation with control antibodies (IgG) or
antibodies directed against RNA polymerase I (Pol I) and visualized
by western blots. Pictures are representatives from at least three inde-
pendent experiments.
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reached after transcription for 20min.
Using non-labeled nucleotides for transcription start
we stopped transcription after different time points by
crosslinking the proteins to the template with formalde-
hyde. The indicated proteins were immunoprecipitated
and the crosslinked template isolated and quantiﬁed
in semi-quantitative PCR. This allows a time course of
the association of a particular protein with the rDNA
template in vitro. RNA polymerase I could be quantita-
tively crosslinked to the rDNA until 10min after start of
transcription, whereas TIF-IA left the template directly
after transcription start (Figure 3B). TFIIH was as long
as the RNA polymerase I associated with the rDNA,
indicating that TFIIH does not leave the enzyme. As the
elongation of RNA polymerase I occurs with 30-nt/s (24),
the used template is transcribed in 13s. Our new method
shows, that the polymerase and TFIIH are associated with
the template for 10min before entering the elongation
mode and may undergo conformational changes after
TIF-IA left the template.
In summary, template-immunoprecipitation (TIP)
analysis revealed that TFIIH binds as long to the rDNA
as RNA polymerase I. This new developed assay allows to
study steps after transcription initiation e.g. promoter
clearance of RNA polymerase I, that so far were difﬁcult
to address.
Mutations in TFIIH affect RNA polymerase I
transcription
In recent reports it has been shown that mutations in the
CSB protein found in CS patients impair RNA poly-
merase I elongation (4,25,22). To study the functional
consequences of CS mutations in TFIIH for RNA poly-
merase I transcription, we isolated RNA from exponen-
tially growing cells with mutations in XPA from a XP
patient as a control, or XPB and XPD mutant cells
from CS patients with monoallelic expression of mutant
XPB or XPD subunits. Analysis of the 45S precursor
rRNA allows a determination of ongoing RNA polymer-
ase I transcription at the time-point of harvest and showed
a considerable reduction of rRNA synthesis in cells from
CS patients in real-time PCR analysis and in northern
blots (Figure 4A).
In an attempt to correct the reduction in rRNA tran-
scription, we transfected the wild-type TFIIH subunits
into the cells with mutant TFIIH. Transfection of
wt-XPB into the XPB/CS cell line resulted in a signiﬁcant
upregulation of rRNA transcription as detected by quan-
titative PCR. Moreover, wild-type XPD transfection into
the XPD/CS lymphoblastoid cells clearly stimulated
rRNA transcription (Figure 4B). Thus wild-type TFIIH
subunits are able to restore the transcriptional defect of
rDNA transcription in TFIIH/CS cells.
With nuclear extracts from the TFIIH mutant cells we
asked the question whether mutation in TFIIH is followed
by a reduced rDNA transcription activity in vitro and if
so, if this defect can be overcome by the addition of
puriﬁed TFIIH. In vitro transcription analysis uncovered
a severely reduced transcriptional activity that could
be rescued by the addition of afﬁnity-puriﬁed
TFIIH (Figure 4C). Moreover, the reconstitution of
these extracts by puriﬁed TFIIH was abolished by pre-
incubation of TFIIH with TFIIH antibody. Heat-
inactivation of the antibody resulted in a clear stimulation
of Pol I transcription by TFIIH.
TFIIH is necessary for RNA polymerase I transcription
at a step subsequent to initiation (3) and TFIIH associ-
ates with the polymerase. We tested the effect of
TFIIH on non-speciﬁc RNA polymerase I transcription.
A amanitin resistant transcription was reduced in nuclear
extracts of TFIIH/CS cells and could be stimulated by the
addition of afﬁnity puriﬁed TFIIH thus indicating that
TFIIH stimulates the elongation activity of the enzyme
(Figure 4D).
A tailed template derived from the pUC plasmid was
employed to assay RNA polymerase I transcription in the
presence of a-amanitin. Addition of puriﬁed TFIIH
resulted in a clear stimulation of RNA polymerase I
activity (Figure 4E). As this end-to-end transcription
assay reﬂects the elongation activity of the enzyme (26),
TFIIH stimulates RNA polymerase I transcription by
enhancing the elongation step of the transcription cycle.
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Figure 3. TFIIH associates with the rDNA throughout the transcrip-
tion process. (A) Kinetics of single-round transcription with initiated
complexes. Transcription was started after pre-incubation with the ﬁrst
2nt and restricted to a single round by addition of sarcosyl. Bars rep-
resent the mean value of three independent experiments. A typical auto-
radiograph of a single-round transcription from initiated complexes
formed at the pHrP2 template is shown below. (B) TIP experiments
showing the time-course of the association of RNA polymerase I,
TFIIH and TIF-IA with the rDNA in single-round transcriptions.
Nuclear extracts were pre-incubated with rDNA template in the
presence of the ﬁrst 2nt and reaction was started by addition of the
lacking NTPs. After the indicated time-points formaldehyde was added
to stop the reaction and to crosslink proteins to the DNA. These
complexes were subsequent used for immunoprecipitation with the
indicated antibodies and template association was detected in PCR re-
actions with primers directed against the human rDNA promoter.
Pictures are representatives from at least three independent
experiments.
654 Nucleic Acids Research, 2012,Vol. 40,No. 2CS mutations in TFIIH impair RNA polymerase I tran-
scription in vivo and in vitro and can be rescued by trans-
fection of wild-type TFIIH subunits in vivo and by
addition of puriﬁed TFIIH in vitro.
CS mutations in XPB and XPD reduce the afﬁnity of
TFIIH to the rDNA
As mutations in TFIIH impair RNA polymerase I elong-
ation, we next asked if mutations in TFIIH are
accompanied by a decreased binding of TFIIH to the
rDNA in vivo. ChIP analysis of chromatin isolated from
lymphoblastoid cells of an XP-patient or donors with
CS-mutations in XPB and XPD was used to address this
question. TFIIH antibodies precipitated promoter and
gene-internal sequences of the rDNA from chromatin of
a XPA patient (Figure 5A). Mutation in XPB allows
promoter-binding, but not binding of TFIIH to
gene-internal sequences as primers generated against
gene-internal sequences did not amplify products from
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Figure 4. RNA polymerase I transcription is reduced in TFIIH/CS cells and can be rescued by wild-type TFIIH subunits in vivo and puriﬁed TFIIH
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(C) Promoter-dependent RNA polymerase I in vitro transcription with the indicated nuclear extracts and puriﬁed TFIIH. Antibodies against the
TFIIH subunit p44 inhibit the reconstitution (anti-TFIIH) and are inactivated by heat treatment (anti-TFIIH*). (D) Non speciﬁc RNA polymerase I
transcription is stimulated by TFIIH. Soniﬁed calf-thymus DNA was used as a template in the presence of a-amanitin with the indicated nuclear
extracts and puriﬁed TFIIH. (E) The autoradiography shows end-to-end transcription of RNA polymerase I performed with a pUC template without
rDNA promoter in the presence of a-amanitin. Pictures are representatives from at least three independent experiments.
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XPD completely abolished binding of TFIIH to the
rDNA in vivo as no rDNA sequences could be ampliﬁed.
We next tested whether in vitro TFIIH presents
reduced afﬁnity to the rDNA. A human rDNA template
was immobilized with magnetic beads and used to isolate
initiation complexes from nuclear extracts from either
HeLa cells, or cells from patients with XPA or XP/CS
and bound proteins were analyzed on immunoblots. As
demonstrated in Figure 5B, RNA polymerase I and
UBF bound to the immobilized rDNA to the same
extent independent of differences in the nuclear extracts.
However, TFIIH mutations in XPB or XPD severely
reduced the afﬁnity of the complete TFIIH complex to
the rDNA, indicating that the binding to the rDNA is
mediated by the helicase subunits of TFIIH. Moreover,
these results show that RNA polymerase I is efﬁciently
recruited to the rDNA even in the absence of functional
TFIIH. When these experiments were performed under
in vitro transcription conditions, the lack of TFIIH
resulted in an impaired RNA polymerase I single-round
transcription (Figure 5C). There are no shorter transcripts
or smears detectable in the gel, indicating that reduced
TFIIH at the promoter does not result in the generation
of partial transcripts (Supplementary Data). In summary
CS mutations in TFIIH result in a reduced afﬁnity of
TFIIH to the rDNA in vivo and in vitro and impair
RNA polymerase I transcription.
TFIIH does not inﬂuence the stability of the initiation
complex of RNA polymerase I
CS mutations in TFIIH are accompanied by a reduced
TFIIH binding to the rDNA promoter in vivo and
in vitro. To investigate if this lack of TFIIH is followed
by a reduced residence time of the polymerase, we per-
formed template-immunoprecipitation (TIP) analysis
with extracts from CS-cells. Experiments with nuclear
extracts from cells of a XPA patient showed that TFIIH
and RNA polymerase I display a comparable time course
of rDNA binding (Figure 6). In nuclear extracts from
XPB/CS and XPD/CS cells a rDNA binding of TFIIH
was barely detectable, whereas RNA polymerase I
showed similar binding kinetics to the rDNA as in the
XPA control cells. The lack of TFIIH does not result in
a prolonged residence time of the polymerase indicating
that RNA polymerase I does not encounter promoter
proximal stalling and that promoter clearance is not de-
pendent on TFIIH. These results further support our
ﬁnding that TFIIH does not inﬂuence the ﬁrst steps of
transcription like pre-initiation complex formation, for-
mation of the ﬁrst phosphodiester bonds and promoter
clearance, but is essential at the subsequent step of elong-
ation of RNA polymerase I transcription.
DISCUSSION
TFIIH exempliﬁes the intimate structural link of tran-
scription and DNA repair, and it exerts multiple different
functions in both processes. In RNA polymerase II tran-
scription TFIIH is necessary for promoter opening by the
ATPase domain of XPB (27), promoter escape (7), phos-
phorylation of the CTD of RNA polymerase II (28) and
transactivation of a variety of promoters (29). In NER,
TFIIH opens the DNA double strand by the helicase sub-
units XPB and XPD (30). Mutations in TFIIH can result
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Figure 5. Reduced binding of mutant TFIIH to the rDNA in vitro and
in vivo.( A) Quantitative PCR analysis of ChIP of the indicated cell lines
with antibodies against RNA polymerase I and TFIIH (anti-cdk7) as
indicated above. Primer were directed against the IGS, promoter or
gene-internal regions (H4, H8). (B) Immobilized complexes were formed
with the indicated nuclear extracts, washed with buffer AM50 and
analyzed after urea elution on immunoblots. (C) Immobilized complexes
from nuclear extracts as indicated above were challenged by addition of
nucleotides and radioactive UTP. Sarcosyl was added to limit transcrip-
tion to a single round. Synthesized RNA was isolated after 60min and
subject to eletrophoresis and autoradiography. Pictures are representa-
tives from at least three independent experiments.
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XP and the premature aging disorders CS and TTD.
Recently we and others could show, that TFIIH is essen-
tial for rDNA transcription by RNA polymerase I (3–5).
However the precise molecular function of TFIIH in RNA
polymerase I transcription remained undeﬁned. Here, we
identiﬁed the step of transcription of RNA polymerase I
that is dependent on TFIIH. TFIIH is an elongation
factor of RNA polymerase I and CS mutations in the
helicase subunits of TFIIH reduce the afﬁnity of TFIIH
to the rDNA in vivo and in vitro and impair RNA poly-
merase I transcription.
We unraveled that TFIIH binds the whole rDNA gene
in vivo. The ChIP experiments also demonstrate a binding
of TFIIH to the rDNA promoter. TFIIH may be recruited
to the rDNA promoter by its interaction with the enzyme
or by interaction with the central initiation factor SL1/
TIF-IB as shown in previous publications, but does not
contribute to initiation (3,4). According to an alternative
function to initiation of TFIIH in Pol I transcription, the
ChIP experiments revealed that TFIIH binds to
gene-internal regions. This indicates a possible function
of TFIIH in a step after initiation as promoter clearance
or elongation. The hypothesis that TFIIH is not a mere
initiation factor in RNA polymerase I transcription is
further supported by the experiments showing an associ-
ation of TFIIH with the enzyme after transcription and
the experiments with the newly developed method of TIP.
They demonstrated that TFIIH is connected with the
rDNA as long as the enzyme itself. These results are in
accordance with previous studies by Hoogstraten present-
ing evidence that TFIIH stays for 2–10s at a RNA poly-
merase II promoter, where it is the last factor to enter the
initiation complex and the ﬁrst to leave. The residence
time at the rDNA was up to 25s indicating a differing
function of TFIIH in rRNA transcription than in tran-
scription by RNA polymerase II (5).
We further investigated the consequences of CS muta-
tions in TFIIH for rDNA transcription. The XPB/CS and
XPD/CS cells were chosen for the following reasons: ﬁrst:
both cell lines exhibit mutations that result in one
non-expressed null allele of either XPB or XPD and one
expressed allele with a deﬁned mutation (17,14); allowing
easier interpretation of results than from two different
mutant expressed alleles; second: a former publication
described already a disturbance of the CSB-RNA poly-
merase I–TFIIH complex in these cells (4); third: as CS
mutations in CSB affect RNA polymerase I transcription
elongation (4,22) we asked whether RNA polymerase I
transcription elongation might generally be defective in
CS. RNA polymerase I transcription is severely affected
in both cell lines in vivo and in vitro. Cellular rRNA syn-
thesis can signiﬁcantly be stimulated by transfection of the
wild-type TFIIH subunit indicating that rRNA transcrip-
tion in vivo is dependent on the integrity of the TFIIH
complex. In vitro transcription can speciﬁcally be rescued
by afﬁnity-puriﬁed TFIIH and reconstitutes promoter-
dependent and end-to-end non-speciﬁc transcriptional
activity of RNA polymerase I that reﬂects the elongation
activity of the enzyme (26). The western blots with
nuclear extracts show that the mutant mono-allelic
TFIIH subunits are reduced in comparison to controls
(Supplementary Data); however, mutation in the
C-terminus of XPB or mutation in the DNA-binding
domain of XPD severely reduced the afﬁnity of the
complete TFIIH complex to the rDNA in vivo and
in vitro as shown in ChIP experiments and experiments
with immobilized complexes. The reduction of XPB or
XPD subunits in nuclear extracts as detected in western
blots (Supplementary Data) should result in a 50%
reduced binding and activity of TFIIH in both cell lines.
For XPD mutant cells and extracts there is no binding to
the rDNA in vivo and a severely reduced binding in vitro
detectable. This argues for a qualitative dysfunction of
TFIIH in these mutant cells. The binding of TFIIH to
the rDNA might be mediated by the helicase subunits of
TFIIH although their activity is not needed in RNA poly-
merase I transcription (3). Our data imply that TFIIH
does not inﬂuence the efﬁciency of promoter binding
or the initiation rate of RNA polymerase I, but stimulates
the elongation rate of the enzyme. Semi-quantitative
(Supplementary Data) and quantitative PCR analysis
(Figure 5A) of gene-internal regions do not show a
comparable reduction in RNA polymerase I loading
when TFIIH is severely reduced. As this reduction
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transcription elongation velocity might be the reason. As
in vivo experiments of former publications imply an essen-
tial role of TFIIH in RNA polymerase I transcription
(3,31), TFIIH might be essential for the processivity of
the enzyme and low levels of TFIIH in the XPB/XPD
cells at gene-internal regions of the rDNA might be
below the detection limit of the assays. Alternatively,
TFIIH might be indispensable for RNA polymerase I to
read through damaged, oxidized templates resulting in
reduced elongation. Such a failure of extracts from CS
cells was shown in vitro for RNA polymerase II transcrip-
tion with the same XPB/CS cell line as used in our
study (32). Failure to read through oxidized template
may be sensed by the cell as massive DNA damage and
provoke cellular responses that result in premature aging.
Moreover, TFIIH might be critical to resolve RNA/DNA
intermediates during transcription elongation as the
rDNA is densely packed in the nucleolus.
RNA polymerase I completely leaves the rDNA
promoter even in the absence of TFIIH suggesting that
RNA polymerase I does not encounter promoter proximal
stalling in the absence of TFIIH as RNA polymerase II
(7). However, in the absence of TFIIH RNA polymerase I
does not enter a productive mode, indicating that TFIIH
is essential for RNA polymerase I transcription elong-
ation. Further support of our ﬁndings that TFIIH does
not inﬂuence promoter proximal stability of RNA poly-
merase I is provided by TIP. We expected an instability of
RNA polymerase I in the absence of TFIIH, but this assay
shows that the enzyme–DNA interaction in TFIIH
mutant extracts is as long stable as in TFIIH competent
extracts. This assay does not investigate elongation, as the
elongation phase is quite fast with 30nt/s (24) but demon-
strates, that RNA polymerase I does not leave the rDNA
promoter directly after TIF-IA release but undergoes
TFIIH-independent transitions until it enters the
TFIIH-dependent stage of elongation.
Mutations in CSB, that accounts for 70% of CS cases,
repress elongation by RNA polymerase I (22). Here we
identiﬁed a common function of three genes that, when
mutated cause CS. CSB and TFIIH with its helicase
subunits XPB and XPD are involved in transcription
elongation by RNA polymerase I. RNA polymerase I
transcription accounts for up to 60% of total transcription
in a growing cell and disturbances in ribosomal biogenesis
(ribosomal stress) are followed by an imbalance of the
rRNA components and ribosomal proteins. Ribosomal
proteins like L5 and L11 target MDM2 and stabilize
p53 (33,34). Ribosomal stress through inhibition of
RNA polymerase I transcription is followed by p53 de-
pendent apoptosis (35), a typical hallmark of CS (36).
Impaired RNA polymerase I transcription elongation
and ribosomal stress might contribute to the pathogenesis
of CS by sensitizing cells to apoptosis.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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